Related Experiment Videos
Cancer symptom clusters: clinical and research methodology
Jordanka Kirkova1, Aynur Aktas, Declan Walsh
1Taussig Cancer Institute, Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Journal of Palliative Medicine
|August 25, 2011
Summary
Cancer patients often experience symptom clusters. This review identified common clusters like fatigue-pain and nausea-vomiting, highlighting their clinical relevance and need for standardized research methods.
Area of Science:
- Oncology
- Symptom Science
- Clinical Research
Background:
- Cancer patients frequently experience multiple symptoms concurrently.
- These symptoms often manifest as distinct groups or clusters.
- Understanding these symptom clusters is crucial for effective patient care.
Purpose of the Study:
- To identify common cancer symptom clusters (SC).
- To explore the clinical relevance of identified SC.
- To examine the research importance and methodologies of SC studies.
Main Methods:
- Conducted a comprehensive literature search of published studies and review articles on cancer SC.
- Identified and analyzed 65 relevant reports.
- Compared clinical and statistical approaches to SC identification.
Main Results:
- Two primary methods for SC identification emerged: clinical observation and statistical analysis.
- Clinically identified SC included fatigue-pain and depression-fatigue, showing moderate correlations.
- Statistically identified SC consistently included nausea-vomiting and anxiety-depression, with some symptoms appearing in multiple clusters.
Conclusions:
- Several key cancer symptom clusters, including nausea-vomiting and anxiety-depression, have been consistently identified.
- Symptom cluster identification is a valuable research tool with significant clinical potential.
- Further research is needed to standardize analytical techniques and expand knowledge on SC clinical importance.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
02:12What is Cancer?
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...